Trials / Completed
CompletedNCT04159961
Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers
A Randomized, Open-label, Parallel Design Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic of DWJ211 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, open-label, parallel design Phase I clinical trial to evaluate the safety/tolerability and pharmacokinetic of DWJ211 in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ211 | Inject the Drug into submental fat and abdominal fat via subcutaneous |
Timeline
- Start date
- 2019-12-24
- Primary completion
- 2020-04-21
- Completion
- 2020-04-21
- First posted
- 2019-11-12
- Last updated
- 2024-04-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04159961. Inclusion in this directory is not an endorsement.